China Regenerative Medicine International Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was HKD 74.322 million compared to HKD 48.512 million a year ago. Net income was HKD 23.895 million compared to net loss of HKD 148.668 million a year ago. Basic earnings per share from continuing operations was HKD 0.00851 compared to basic loss per share from continuing operations of HKD 0.01374 a year ago. For the half year, sales was HKD 115.302 million compared to HKD 49.307 million a year ago. Net income was HKD 16.239 million compared to net loss of HKD 163.734 million a year ago. Basic earnings per share from continuing operations was HKD 0.00981 compared to basic loss per share from continuing operations of HKD 0.02248 a year ago.